Manulife (Manufacturers Life Insurance)’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,745
Closed -$57.5K 2946
2024
Q4
$57.5K Buy
20,745
+45
+0.2% +$125 ﹤0.01% 2922
2024
Q3
$108K Sell
20,700
-727
-3% -$3.8K ﹤0.01% 2850
2024
Q2
$95.6K Buy
21,427
+2,690
+14% +$12K ﹤0.01% 2833
2024
Q1
$144K Sell
18,737
-5,764
-24% -$44.2K ﹤0.01% 2692
2023
Q4
$104K Buy
24,501
+9,949
+68% +$42.4K ﹤0.01% 2806
2023
Q3
$61.1K Sell
14,552
-138
-0.9% -$580 ﹤0.01% 2928
2023
Q2
$81.8K Buy
+14,690
New +$81.8K ﹤0.01% 2910